Greenwich Biosciences, Inc.
Registered Principal Details
Business Or Interest:
Pharmaceutical manufacturing and healthcare
Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries
CEO Name:
Justin Gover
Designated Agent for Filer
Pharmaceutical manufacturing and healthcare
Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries
CEO Name:
Justin Gover
Designated Agent for Filer
Contact
JUS
Jennie U Skelton
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
(415) 610-7604
greenwichbio@politicomlaw.com
http://www.greenwichbiosciences.com
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
(415) 610-7604
greenwichbio@politicomlaw.com
http://www.greenwichbiosciences.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Annie Early | Exclusive Duties No | Authorized On 12/20/2018 | Withdrawn On N/A |
| Jeremey J Shepherd | Exclusive Duties No | Authorized On 12/20/2018 | Withdrawn On N/A |
| Cassi Baker | Exclusive Duties No | Authorized On 7/9/2019 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 206
Relating to: regulating hemp, providing an exemption from emergency rule procedures, granting rule-making authority, and making an appropriation. (FE)
Bill Text and History
5/15/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: regulating hemp, providing an exemption from emergency rule procedures, granting rule-making authority, and making an appropriation. (FE)
Bill Text and History
For
Notification Date5/15/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 188
Relating to: regulating hemp, providing an exemption from emergency rule procedures, granting rule-making authority, and making an appropriation. (FE)
Bill Text and History
2019 Wisconsin Act 68
5/15/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: regulating hemp, providing an exemption from emergency rule procedures, granting rule-making authority, and making an appropriation. (FE)
Bill Text and History
2019 Wisconsin Act 68
For
Notification Date5/15/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Administrative Rulemaking Proceedings
Agency Name
Controlled Substances Board (CSB)
Subject
Scheduling of FDA approved cannabidiol drugs
Scope Statement
SS 121_18
1/22/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Controlled Substances Board (CSB)
Subject
Scheduling of FDA approved cannabidiol drugs
Scope Statement
SS 121_18
For
Notification Date1/22/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.
Development, drafting or introduction of a proposal relating to
Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.
Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
7/8/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
7/8/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
all matters affecting the regulation and reimbursement of CBD products and the effects on consumers
all matters affecting the regulation and reimbursement of CBD products and the effects on consumers
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2019 January - June $30,483.29 |
2019 July - December $27,639.45 |
2020 January - June $28,628.28 |
2020 July - December $27,000.00 |
Total $113,751.02 |
| Total Hours Communicating | 2019 January - June 23.00 |
2019 July - December 9.00 |
2020 January - June 7.00 |
2020 July - December 0.00 |
Total 39.00 |
| Total Hours Other | 2019 January - June 42.25 |
2019 July - December 15.75 |
2020 January - June 24.75 |
2020 July - December 8.25 |
Total 91.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: regulating hemp, providing an exemption from emergency rule procedures, granting rule-making authority, and making an appropriation. (FE)
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 15% |
2019 July - December 15% |
2020 January - June |
2020 July - December |
Total 11% |
Relating to: regulating hemp, providing an exemption from emergency rule procedures, granting rule-making authority, and making an appropriation. (FE)
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 35% |
2019 July - December 70% |
2020 January - June |
2020 July - December |
Total 31% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 10% |
2019 July - December |
2020 January - June |
2020 July - December |
Total 5% |
Topics Not Yet Assigned A Bill Or Rule Number
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 30% |
2019 July - December |
2020 January - June |
2020 July - December 10% |
Total 16% |
Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June |
2019 July - December |
2020 January - June 75% |
2020 July - December |
Total 18% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication